Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation

Anna Solta(Comprehensive Cancer Center Vienna), Karin Schelch(Comprehensive Cancer Center Vienna)

Cancer & Metabolism

March 31, 2025

10.1186/s40170-025-00382-6

Cited by 9

Related Papers

Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer

|Molecular Cancer|2024|46

Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair

|Clinical Cancer Research|2023|30

<scp>YB</scp> ‐1 regulates mesothelioma cell migration via snail but not <scp>EGFR</scp> , <scp>MMP1</scp> , <scp>EPHA5</scp> or <scp>PARK2</scp>

|Molecular Oncology|2022|5